Skip to main content
Premium Trial:

Request an Annual Quote

Tm BioScience Shareholders OK Luminex's Acquisition Bid

NEW YORK (GenomeWeb News) — Shareholders and option holders in Tm Bioscience have approved a plan by Luminex to buy the Canadian company, Tm said today.
 
The company said the acquisition now will go before an Ontario Superior Court Justice for review on Feb. 27. If the court approves the deal it should close the following day, Tm said.
 
The acquisition was originally announced last December.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.